Azithromycin vs Tofacitinib

Azithromycin vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Azithromycin and Tofacitinib.

Mechanism of Action

Azithromycin: Binds 50S ribosomal subunit, inhibiting bacterial protein synthesis.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Azithromycin — 68 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Azithromycin — C38H72N2O12; Tofacitinib — C16H20N6O.

Molecular Weight: Azithromycin — 748.9840 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Azithromycin — Small molecule; Tofacitinib — Small molecule.